101 related articles for article (PubMed ID: 23091851)
1. [Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-gamma2 gene polymorphism].
Lavrenko AV; Shlykova OA; Kutsenko LA; Mamontova TV; Kaĭdashev IP
Ter Arkh; 2012; 84(9):35-40. PubMed ID: 23091851
[TBL] [Abstract][Full Text] [Related]
2. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
[TBL] [Abstract][Full Text] [Related]
3. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kucukhuseyin O; Akadam-Teker B; Kurt O; Eronat AP; Tekeli A; Bugra Z; Ozturk O
Gene; 2013 Jul; 523(1):20-6. PubMed ID: 23583468
[TBL] [Abstract][Full Text] [Related]
4. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
[TBL] [Abstract][Full Text] [Related]
5. [Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus].
Tepliakov AT; Maianskaia SD; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV; Lukinov AV; Derbeneva NV; Frants MV; Shilov SN
Ter Arkh; 2009; 81(3):62-9. PubMed ID: 19459427
[TBL] [Abstract][Full Text] [Related]
6. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease.
Erkkilä AT; Lindi V; Lehto S; Pyörälä K; Laakso M; Uusitupa MI
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):53-9. PubMed ID: 12189904
[TBL] [Abstract][Full Text] [Related]
7. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
Stefański A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Moleda P; Pilarska K
J Hum Hypertens; 2006 Sep; 20(9):684-92. PubMed ID: 16625233
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of short-term metformin application in complex treatment of patients with coronary artery disease and concomitant metabolic syndrome].
Lavrenko AV; Rasin MS; Kutsenko LA; Mikitiuk MV; Solokhina IL; Mamontova TV; Kaĭdashev IP
Lik Sprava; 2010; (7-8):65-71. PubMed ID: 21714290
[TBL] [Abstract][Full Text] [Related]
9. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the Gly972Arg, SNP43 and Prol2Ala polymorphisms of the genes IRS1, CAPN10 and PPARG2 on secondary failure to sulphonylurea and metformin in patients with type 2 diabetes in Yucatán, México].
García-Escalante MG; Suárez-Solís VM; López-Avila MT; Pinto-Escalante Ddel C; Laviada-Molina H
Invest Clin; 2009 Mar; 50(1):65-76. PubMed ID: 19418728
[TBL] [Abstract][Full Text] [Related]
11. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
12. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
[TBL] [Abstract][Full Text] [Related]
13. Increased metformin dosage suppresses pro-inflammatory cytokine levels in systemic circulation and might contribute to its beneficial effects.
Amoani B; Sakyi SA; Mantey R; Laing EF; Ephraim RD; Sarfo-Katanka O; Koffie S; Obese E; Afranie BO
J Immunoassay Immunochem; 2021 May; 42(3):252-264. PubMed ID: 33444083
[TBL] [Abstract][Full Text] [Related]
14. PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China.
Pei Q; Huang Q; Yang GP; Zhao YC; Yin JY; Song M; Zheng Y; Mo ZH; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2013 Feb; 34(2):255-61. PubMed ID: 23147557
[TBL] [Abstract][Full Text] [Related]
15. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
16. Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.
Kraemer de Aguiar LG; Laflor CM; Bahia L; Villela NR; Wiernsperger N; Bottino DA; Bouskela E
Diabet Med; 2007 Mar; 24(3):272-9. PubMed ID: 17263761
[TBL] [Abstract][Full Text] [Related]
17. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M; Rizvi AA; Patti AM; Nikolic D; Giglio RV; Castellino G; Li Volti G; Caprio M; Montalto G; Provenzano V; Genovese S; Ceriello A
Cardiovasc Diabetol; 2016 Dec; 15(1):162. PubMed ID: 27912784
[TBL] [Abstract][Full Text] [Related]
19. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
Andrulionytè L; Zacharova J; Chiasson JL; Laakso M;
Diabetologia; 2004 Dec; 47(12):2176-84. PubMed ID: 15592662
[TBL] [Abstract][Full Text] [Related]
20. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control.
Mughal MA; Jan M; Maheri WM; Memon MY; Ali M
J Pak Med Assoc; 2000 Nov; 50(11):381-6. PubMed ID: 11126815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
